Primary Leiomyosarcoma of the Mandibular Gingiva
Journal Title: Global Journal of Cancer Therapy - Year 2016, Vol 2, Issue 1
Abstract
Primary oral leiomyosarcomas are exceptionally rare lesions often associated with poor prognosis. We report a case of leiomyosarcoma arising in the anterior mandibular gingiva, which is a non-prevalent site of occurrence. Clinically, the tumor was far from being firm and solid as it is usually described in the literature. Light microscopy failed to confirm the true nature of the lesion on the biopsy specimen.
Authors and Affiliations
Zanakis Stylianos N, Lyris Vasileios, Kyriakou Sotirios, Agrogiannis George, Korkolopoulou Penelope
Keywords
Related Articles
- EP ID EP352835
- DOI 10.17352/2581-5407.000006
- Views 101
- Downloads 0
The Promise of Disease Management in Greece
Background: Disease Management (DM) is an approach to health care that coordinates resources across the entire health care delivery system and throughout the course of a disease. Objectives: The purpose of the present s...
Total Oncology is necessary for Japanese new era
Still in Japan, medical oncologists need to play a main role and work a lot of tasks by themselves in cancer chemotherapy. The situation of cancer chemotherapy has progressed day by day and considering the current enviro...
A Novel Small-Molecule Integrin Antagonist Inhibits Cells Adhesion Followed By Anoikis in Endothelial Cells - A Comparative Analysis with Cilengitide
Background: Despite the crucial role of integrin receptors in cancer pathogenesis and massive efforts towards establishing clinically relevant drugs, to the present no effective integrin antagonist for the treatment of m...
Is it Time for the Introduction of Colostomy Free Survival in Rectal Cancer Patients
The rectum is considered the straight part of the bowel although it’s not straight with at least three folds. Sometimes defined as the last 12 cm of the large bowel other consider it as the last 15 cm. Surgeons mark it s...
Identification of Combinatorial Drugs that Synergistically Kill both Eribulin-Sensitive and Eribulin-Insensitive Tumor Cells
Eribulin sensitivity was examined in a panel of twenty-five human cancer cell lines representing a variety of tumor types, with a preponderance of breast and lung cancer cell lines. As expected, the cell lines vary in se...